FORA Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,479
Closed -$274K 535
2023
Q4
$274K Buy
4,479
+603
+16% +$35.8K 0.02% 390
2023
Q3
$222K Buy
+3,876
New +$234K 0.02% 425
2023
Q2
Sell
-7,234
Closed -$453K 555
2023
Q1
$453K Buy
+7,234
New +$452K 0.05% 369
2021
Q2
Sell
-2,199
Closed -$97K 1078
2021
Q1
$97K Buy
+2,199
New +$92.4K 0.03% 414
2020
Q4
Sell
-499
Closed -$18K 1085
2020
Q3
$18K Buy
+499
New +$18.6K 0.01% 598
2020
Q2
Sell
-1,789
Closed -$66K 1207
2020
Q1
$66K Buy
+1,789
New +$69.5K 0.01% 710

Other funds holding PBH

FORA Capital's PBH Position: Q1 2024 in Review

FORA Capital sold out of Prestige Consumer Healthcare (PBH) in Q1 2024, closing a stake of 4,479 shares — an estimated $274K sold.

FORA Capital first reported a position in PBH in Q1 2020 and held it in 6 quarters. The position peaked at $453K in Q1 2023. 312 funds tracked by Wall St. Rank hold PBH as of Q1 2024.

  • FORA Capital reported no remaining Prestige Consumer Healthcare position as of Q1 2024 after selling out during the quarter.
  • FORA Capital sold 4,479 Prestige Consumer Healthcare shares in Q1 2024, an estimated $274K.
  • FORA Capital first reported a position in Prestige Consumer Healthcare in Q1 2020 and held it in 6 quarters.
  • FORA Capital's Prestige Consumer Healthcare position peaked at $453K in Q1 2023.
  • 312 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2024.

Based on FORA Capital's 13F filing for Q1 2024, filed 2 May 2024.